CK Life Sciences International Holdings (FRA:LSI) Short Ratio


FRA:LSI CK Life Sciences International Holdings Inc FRA:LSI
34 GF Score
Price €0.07
GF Value €0.08
! 5 Warning Signs
View Full Analysis

What is CK Life Sciences International Holdings Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:LSI
34GF Score
CK Life Sciences International Holdings Inc FRA:LSI
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is CK Life Sciences International Holdings (FRA:LSI) Overvalued in 2026?

Based on GuruFocus' analysis, CK Life Sciences International Holdings stock appears to be undervalued. The current stock price of €0.07 is trading 16.9% below its estimated GF Value™ of €0.08.

Key valuation signals for FRA:LSI:

  • Short Ratio:
  • GF Value™: €0.08 vs. price of €0.07 (16.9% below fair value)
  • GF Score™: 34/100 with 5 warning signs

No single metric tells the full story. See the FRA:LSI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


CK Life Sciences International Holdings Business Description

Other Exchanges 00775:Hong Kong
Address 2 Dai Fu Street, Tai Po Industrial Estate, Tai Po, Hong Kong, HKG
CK Life Sciences International Holdings Inc is an international life sciences company. It is engaged in research and development, manufacturing, commercialization, marketing and selling of health and agriculture-related products, as well as investment in a portfolio of vineyards, and various financial and investment products. Its pipeline includes Seviprotimut-L, TTX-MC138, Seviprotimut-L + TTX-MC138, TTX-RIGA, Halneuron, among others. Its segments include Agriculture-related, Nutraceutical, and Pharmaceuticals & Diagnostics R&D with the majority of the revenue deriving from Nutraceutical segment. Geographically it operates in Asia Pacific that derives the majority of the revenue and North America.
34GF Score

Get the complete analysis for FRA:LSI

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.07
Price
€0.08
GF Value